Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000171.xml
Dtsch Med Wochenschr 2011; 136(22): 1194-1196
DOI: 10.1055/s-0031-1280539
DOI: 10.1055/s-0031-1280539
Rheumatologie | Commentary
Rheumatologie
© Georg Thieme Verlag KG Stuttgart · New York
Vaskulitis
VasculitisFurther Information
Publication History
Publication Date:
24 May 2011 (online)
![](https://www.thieme-connect.de/media/dmw/201122/lookinside/thumbnails/10.1055-s-0031-1280539-1.jpg)
Schlüsselwörter
Vaskulitis - ANCA - EULAR-Empfehlungen - Wegener-Granulomatose - Riesenzellarteriitis - Takayasu-Arteriitis - Kryoglobulinämie
Keywords
vasculitis - ANCA - EULAR recommendations - Wegener's granulomatosis - giant cell arteritis - Takayasu's arteritis - cryoglobulinemia
Literatur
- 1 Cartin-Ceba R, Golbin J, Keogh K. et al . Rituximab for induction and maintenance in ANCA-associated vasculitis. Arthritis Rheum. 2010; 62 (Suppl.) S283
- 2 Dammacco F, Tucci F A, Lauletta G. et al . Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia. Blood. 2010; 116 343-353
- 3 Hiemstra T F, Walsh M, Mahr A. et al . Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis. J Am Med Assoc. 2010; 304 2381-2388
- 4 Jones R, Smith R, Guerry M Y. et al . Protocollized versus non-protocollized rituximab treatment for refractory ANCA-associated vasculitis. Arthritis Rheum. 2010; 62 (Suppl.) S283
- 5 Jones R B, Tervaert J W. et al . Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010; 363 211-220
- 6 Mukhtyar C, Guillevin L, Cid M C. et al . EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009; 68 318-323
- 7 Mukhtyar C, Guillevin L, Cid M C. et al . EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009; 68 310-317
- 8 Saadoun D, Resche Rigon M, Sene D. et al . Rituximab plus Peg-Interferon-alpha/ribavirin with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood. 2010; 116 326-334
- 9 Stone J H, Merkel P A. et al . Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010; 363 221-232
- 10 Terrier B, Launay D, Kaplanski G. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis. Arthritis Care Res. 2010; 62 1787-1795
- 11 Walsh M, Merkel P A, Mahr A, Jayne D. Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res. 2010; 62 1166-1173
Prof. Dr. med. Bernhard Hellmich
Kreiskliniken Esslingen gGmbH Klinik Plochingen
Akademisches
Lehrkrankenhaus der Universität Tübingen
Klinik
für Innere Medizin
(Allgemeine Innere Medizin,
Rheumatologie und Klinische Immunologie, Intensivmedizin)
Am
Aussichtsturm 5
73207 Plochingen
Email: b.hellmich@kk-es.de